| Biomarker ID | 528 |
| PMID | 20473869 |
| Year | 2010 |
| Biomarker | miRNA-141 |
| Biomarker Basis | Expression Based |
| Biomolecule | miRNA |
| Source | Serum |
| Subjects | Humans |
| Regulation | Upregulated in PCa |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Pathways Include:- regulation of RNA metabolic process; Gene expression (Transcription); RNA Polymerase II Transcription; nuclear chromosome; DNA-binding transcription factor activity, RNA polymerase II-specific |
| Experiment | Gleason Score >8 Vs Gleason Score 7 |
| Type of Biomarker | Prognostic |
| Cohort | Second validation study took serum samples of 71 patients. Gleason Score >=8(n = 29), Gleason Score 7(n = 42) |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p<0.01 |
| Method Used | qRT-PCR |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Validated on Independent Patient Dataset |
| Technical Name | miRNA-141 |